ATE504308T1 - Antimikrobielle kationische peptide und diese enthaltende formulierungen - Google Patents

Antimikrobielle kationische peptide und diese enthaltende formulierungen

Info

Publication number
ATE504308T1
ATE504308T1 AT02759416T AT02759416T ATE504308T1 AT E504308 T1 ATE504308 T1 AT E504308T1 AT 02759416 T AT02759416 T AT 02759416T AT 02759416 T AT02759416 T AT 02759416T AT E504308 T1 ATE504308 T1 AT E504308T1
Authority
AT
Austria
Prior art keywords
antimicrobial cationic
cationic peptides
formulations containing
containing same
infections
Prior art date
Application number
AT02759416T
Other languages
English (en)
Inventor
Timothy Krieger
Patricia Mcnicol
Original Assignee
Migenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Migenix Inc filed Critical Migenix Inc
Application granted granted Critical
Publication of ATE504308T1 publication Critical patent/ATE504308T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT02759416T 2001-08-21 2002-08-21 Antimikrobielle kationische peptide und diese enthaltende formulierungen ATE504308T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31423201P 2001-08-21 2001-08-21
US10/225,087 US6835536B2 (en) 2001-08-21 2002-08-20 Antimicrobial cationic peptides and formulations thereof
PCT/US2002/026525 WO2003015809A2 (en) 2001-08-21 2002-08-21 Antimicrobial cationic peptides and formulations thereof

Publications (1)

Publication Number Publication Date
ATE504308T1 true ATE504308T1 (de) 2011-04-15

Family

ID=26919289

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02759416T ATE504308T1 (de) 2001-08-21 2002-08-21 Antimikrobielle kationische peptide und diese enthaltende formulierungen

Country Status (8)

Country Link
US (5) US6835536B2 (de)
EP (1) EP1469876B1 (de)
JP (3) JP4932136B2 (de)
AT (1) ATE504308T1 (de)
AU (1) AU2002324752B2 (de)
CA (1) CA2456477C (de)
DE (1) DE60239707D1 (de)
WO (1) WO2003015809A2 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7550558B2 (en) * 2001-06-01 2009-06-23 Fundacao De Ampara A Pesquiso Do Estado De Sao Paolo (Fapesp) Antimicrobial peptides and methods for identifying and using such peptides
US6835536B2 (en) 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
CA2457885A1 (en) 2001-08-24 2003-03-06 Micrologix Biotech Inc. Antimicrobial and anti-inflammatory peptides
US7687454B2 (en) 2001-12-03 2010-03-30 The University Of British Columbia Effectors of innate immunity determination
US7507787B2 (en) * 2001-12-03 2009-03-24 The University Of British Columbia Effectors of innate immunity
US20030144362A1 (en) * 2002-01-28 2003-07-31 Utterberg David S. High viscosity antibacterials for cannulae
US20060128614A1 (en) * 2002-09-20 2006-06-15 Jya-Wei Cheng Antimicrobial peptides with reduced hemolysis and methods of their use
WO2005016960A2 (en) * 2003-08-14 2005-02-24 Diatos Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
US7550430B2 (en) * 2003-08-18 2009-06-23 E.I. Du Pont De Nemours And Company Cationic antimicrobial peptides and compositions
MXPA06002828A (es) * 2003-09-12 2006-06-23 Univ British Columbia Efectores de determinacion de inmunidad innata.
JP4736540B2 (ja) * 2004-05-27 2011-07-27 参天製薬株式会社 眼科用粘稠化剤
CA2567418C (en) * 2004-05-27 2012-12-04 Santen Pharmaceutical Co., Ltd. Viscous agent for ophthalmic use
CA2629751A1 (en) * 2004-11-12 2006-05-18 The University Of British Columbia Antimicrobial peptides
AU2006275417B2 (en) * 2005-08-01 2012-04-12 The Board Of Regents Of The University Of Oklahoma Antifungal peptides and methods of use thereof
EP1916997B1 (de) * 2005-08-05 2018-04-18 Amgen Inc. Pharmazeutische formulierungen aus stabilen wässrigen proteinen und ihre herstellung
US7902327B2 (en) * 2007-05-22 2011-03-08 New York University School Of Medicine Dendrimeric peptides, pharmaceutical compositions and methods of using the same
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
EP2323703A4 (de) * 2008-08-28 2013-11-20 Covidien Lp Umgebungsaktivierte zusammensetzungen, artikel und verfahren
AU2010316006B2 (en) * 2009-11-03 2013-09-26 Lipidor Ab Composition for promoting wound healing
US8916171B2 (en) 2010-04-27 2014-12-23 Topical Sinus Therapeutics, Inc. Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis
WO2012161708A1 (en) * 2011-05-25 2012-11-29 Empire Technology Development Llc Treating lignocellulosic materials
EP3384938A1 (de) 2011-09-12 2018-10-10 Moderna Therapeutics, Inc. Manipulierte nukleinsäuren und verfahren zur verwendung davon
JP5894457B2 (ja) * 2012-02-22 2016-03-30 株式会社Adeka ペプチド含有抗菌性組成物
WO2013142374A1 (en) * 2012-03-23 2013-09-26 Amirobe, Inc. Compositions and uses of antimicrobial materials with tissue-compatible properties
HK1206612A1 (en) 2012-04-02 2016-01-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of secreted proteins
AU2013243952A1 (en) 2012-04-02 2014-10-30 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
ES2981535T3 (es) 2015-11-10 2024-10-09 Visterra Inc Conjugados de molécula de anticuerpo-fármaco que se unen específicamente al lipopolisacárido y usos de los mismos
US20210213096A1 (en) * 2016-02-19 2021-07-15 Forschungszentrum Borstel Leibniz-Zentrum Fur Medizin Und Biowssenschaften Means and methods for treating bacterial infections
ES2994374T3 (en) 2017-01-18 2025-01-23 Visterra Inc Antibody molecule-drug conjugates and uses thereof
CN110167516B (zh) 2017-01-31 2022-08-30 金伯利-克拉克环球有限公司 包含苯甲酸酯的抗细菌组合物及利用该组合物抑制细菌生长的方法
WO2018160791A1 (en) 2017-03-03 2018-09-07 Massachusetts Institute Of Technology Antimicrobial constructs and uses thereof
EP3606543A4 (de) 2017-04-06 2020-12-16 Amicrobe, Inc. Zusammensetzungen und verwendungen eines lokal angewandten antimikrobiellen synthetischen kationischen polypeptids mit verbesserter leistung und sicherheit
WO2020162582A1 (en) * 2019-02-08 2020-08-13 Maruho Co., Ltd. Methods of treating non-virally-induced cancers
WO2020214836A1 (en) 2019-04-16 2020-10-22 Academia Sinica Methods of coating antimicrobial peptides on the biomaterial and the biomaterial coated thereby
EP3797800A1 (de) * 2019-05-02 2021-03-31 Institut National De La Sante Et De La Recherche Medicale - Inserm Hyaluronsäurehydrogele mit verlängerter antimikrobieller wirkung
CN114616240A (zh) * 2019-11-08 2022-06-10 高等教育联邦系统-匹兹堡大学 包含抗微生物肽的组合物
KR20240085798A (ko) 2020-04-03 2024-06-17 비스테라, 인크. 항체 분자-약물 접합체 및 이의 용도
CZ309857B6 (cs) 2022-03-31 2023-12-20 Contipro A.S. Hexapeptid, kompozice zahrnující tento hexapeptid a jejich topické použití

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128617A (en) * 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
US4816449A (en) 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents
JPH0645535B2 (ja) * 1987-05-20 1994-06-15 サンスタ−株式会社 歯槽骨代謝治療用組成物
US5705485A (en) 1987-09-18 1998-01-06 Ethicon, Inc. Gel formulations containing growth factors
US4956184A (en) 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
NZ237202A (en) 1990-02-23 1994-01-26 Bristol Myers Squibb Co Composition containing beta-lactam antibiotic and cationic oligopeptide
US5776892A (en) 1990-12-21 1998-07-07 Curative Health Services, Inc. Anti-inflammatory peptides
AU1579092A (en) 1991-02-27 1992-10-06 Nova Pharmaceutical Corporation Anti-infective and anti-inflammatory releasing systems for medical devices
US5324716A (en) * 1991-06-14 1994-06-28 Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use
US5547939A (en) * 1991-06-14 1996-08-20 The Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use
EP0650494A1 (de) 1992-05-22 1995-05-03 The Children's Hospital Of Philadelphia Gastrointestinale defensine, cdna sequenzes und verfahren zur herstellung und verwendung davon
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
ES2079994B1 (es) 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
GB9224598D0 (en) * 1992-11-24 1993-01-13 Smithkline Beecham Plc Novel compositions
US5436222A (en) 1993-03-15 1995-07-25 The Research Foundation Of State University Of New York Use of platelet factor 4 to treat inflammatory diseases
US5459235A (en) * 1993-03-19 1995-10-17 The Regents Of The University Of California Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
US5681811A (en) 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
US5359030A (en) * 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
NZ275205A (en) * 1993-09-22 1998-03-25 Xoma Corp Use of bactericidal/permeability-increasing protein in treating gram-negative bacterial infection
DK0754050T3 (da) * 1994-01-14 2002-10-21 Xoma Technology Ltd Anti-gram-positive bakterielle fremgangsmåder og materialer
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5505949A (en) 1994-10-13 1996-04-09 Benitez; Juan E. Topical treatment for acne
US5834430A (en) 1995-05-31 1998-11-10 Biosynth S.R.L. Potentiation of antibiotics
US6057291A (en) * 1995-06-02 2000-05-02 University Of British Columbia Antimicrobial cationic peptides
US5877274A (en) 1995-06-02 1999-03-02 University Of British Columbia Antimicrobial cationic peptides
AU6940796A (en) 1995-08-23 1997-03-19 University Of British Columbia, The Antimicrobial cationic peptides and methods of screening for the same
US5994308A (en) 1996-02-28 1999-11-30 Board Of Trustees Of Southern Illinois University Broad spectrum antimicrobial peptides containing a tryptophan triplet and methods of use
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US6180604B1 (en) 1996-08-21 2001-01-30 Micrologix Biotech Inc. Compositions and methods for treating infections using analogues of indolicidin
US6551994B1 (en) 1997-04-10 2003-04-22 Mcgill University Compounds and methods for inhibiting the interaction between α-catenin and β-catenin
US6248343B1 (en) 1998-01-20 2001-06-19 Ethicon, Inc. Therapeutic antimicrobial compositions
US5997893A (en) 1998-01-20 1999-12-07 Ethicon, Inc. Alcohol based anti-microbial compositions with cosmetic appearance
WO1999043357A1 (en) 1998-02-25 1999-09-02 Micrologix Biotech Inc. Indolicidin and cationic peptides conjugated with polymers
US6303575B1 (en) 1998-05-12 2001-10-16 The Regents Of The University Of California Indolicidin analogs and methods of using same
AU4253799A (en) 1998-06-12 2000-01-05 Micrologix Biotech, Inc. Cancer therapy with cationic peptides
US6444645B1 (en) 1998-06-18 2002-09-03 The Regents Of The University Of California Crosslink-stabilized indolicidin analogs
ATE259654T1 (de) 1998-06-26 2004-03-15 Nutricia Nv Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
US6025394A (en) 1999-01-29 2000-02-15 Cell Pathways, Inc. Method for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcohols
WO2000047183A1 (en) * 1999-02-12 2000-08-17 The Procter & Gamble Company Skin sanitizing compositions
US6482799B1 (en) * 1999-05-25 2002-11-19 The Regents Of The University Of California Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
KR20020010920A (ko) * 1999-06-02 2002-02-06 추후제출 각질세포 성장 인자-2 제제
US6835536B2 (en) 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof

Also Published As

Publication number Publication date
CA2456477C (en) 2016-02-16
AU2002324752B2 (en) 2008-07-03
JP5684098B2 (ja) 2015-03-11
JP2005504769A (ja) 2005-02-17
WO2003015809A3 (en) 2004-03-18
US8466102B2 (en) 2013-06-18
US6835536B2 (en) 2004-12-28
WO2003015809A2 (en) 2003-02-27
US9227999B2 (en) 2016-01-05
JP2012041367A (ja) 2012-03-01
US20050049182A1 (en) 2005-03-03
JP2015028082A (ja) 2015-02-12
EP1469876B1 (de) 2011-04-06
DE60239707D1 (de) 2011-05-19
EP1469876A2 (de) 2004-10-27
US20030171281A1 (en) 2003-09-11
US8927487B2 (en) 2015-01-06
US20120202735A1 (en) 2012-08-09
US8138144B2 (en) 2012-03-20
CA2456477A1 (en) 2003-02-27
WO2003015809A9 (en) 2004-04-22
US20130296227A1 (en) 2013-11-07
US20150087580A1 (en) 2015-03-26
JP4932136B2 (ja) 2012-05-16

Similar Documents

Publication Publication Date Title
ATE504308T1 (de) Antimikrobielle kationische peptide und diese enthaltende formulierungen
BR0308090A (pt) conjugados de agentes citotóxicos ou terapêuticos e peptìdios biologicamente ativos
BR0115531A (pt) Tratamento de mucosites
MXPA03010085A (es) Composiciones y su uso en la hiperplasia.
MXPA03009772A (es) Metodos y composiciones para tratar lesiones orales y del esofago.
IS5591A (is) Grunnmassaprótínsamsetningar til sáragræðslu
DE60312211D1 (de) Haarbehandlungsmittel
SE9904377D0 (sv) Pharmaceutical combinations
BR9711986A (pt) Compostos farmac-uticos
NO20073914L (no) Biologisk aktive peptider
SE0003476D0 (sv) Compounds
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
PL368040A1 (en) Substituted 4-aminocyclohexanol derivatives
AU2003206144A1 (en) Pharmaceutical composition for cancer treatment containing p43 protein and paclitaxel, therapy method using the same and use thereof
WO2003053959A8 (de) Heterocyclylaminocarbo nyluracile
WO2002100346A3 (en) (r, r'),(r',s')-amphetaminil, compositions and uses thereof
WO2002100342A3 (en) (s, s'), (s, r')-amphetaminil, compositions and uses thereof
UA32314A (uk) Спосіб лікування некротичного панкреатиту

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties